FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA OKs Datroway for Triple-Negative Breast Cancer

FDA approves Daiichi Sankyos Datroway (datopotamab deruxtecan-dlnk) for adults with unresectable or metastatic triple-negative breast cancer who are n...

latest-news-card-1
Human Drugs

Chronic Hepatitis Delta Virus Infection Treatment Approved

FDA has approved Gilead Sciences Hepcludex (bulevirtide-gmod) for treating chronic hepatitis delta virus (HDV) infection, marking the first FDA-approv...

latest-news-card-1
Human Drugs

Clarity Sought on FDA New Approach Methodologies Guide

Stakeholders suggest ways FDA could clarify a draft guidance on using new approach methodologies in drug development.

latest-news-card-1
Medical Devices

React Health Recalls Ventilators Due to Manufacturing Issue

React Health recalls certain VOCSN V+Pro ventilators due to a manufacturing issue that could lead to undetected oxygen leaks and potentially cause ser...

latest-news-card-1
Medical Devices

Bolton Thoracic Stent Recall is Class 1: FDA

FDA says a Bolton Medical recall of its RelayPro thoracic stent graft system is Class 1.

latest-news-card-1
Human Drugs

Clinical Electronic Structured Protocol Template

FDA publishes for reference only an International Council for Harmonization template on a clinical electronic structured harmonized protocol.

latest-news-card-1
Human Drugs

Comments on Increasing Access to Non-Prescription Drugs

Four stakeholders comment to FDA on ways to increase patient access to nonprescription drugs.

latest-news-card-1
Biologics

FDA to Convene Panel on Modernas mRNA Flu Vaccine

FDA announces a 6/18 advisory committee meeting to review Modernas controversial mRNA-based seasonal influenza vaccine.

Biologics

RFK Jr. Ignores Hill Request on Anti-Vax Activist HHS Role

HHS secretary Robert F. Kennedy Jr. faces renewed scrutiny from Senate Democrats for ignoring requests about the role of longtime anti-vaccine activis...

latest-news-card-1
Human Drugs

Lilly Says Retatrutide Delivered Up to 30% Weight Loss

Eli Lilly reports that its investigational obesity drug retatrutide produced weight-loss results approaching those historically associated with bariat...